Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Monther Al-Alwan
    Stem Cell and Tissue Re-engineering Program
    King Faisal Specialist Hospital and Research Centre
    Saudi Arabia
    MAlwan@kfshrc.edu.sa
    SSCRT

    Dr. Monther AlAlwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professor at Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc. and Ph.D. in Immunology from Dalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance. Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 20 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.   

    More Info.
    Fangyuan Wang
    Medical Research Scientist
    Center for Autoimmune Disease Research, Institute of Rheumatology Research, Department of Rheumatology; Renji Hospital
    Shanghai Jiaotong University
    China
    sunflowerwang@hotmail.com
    SSCRT

    EDUCATION

    2006 – 2009

    M.S. in Microbiological and Biochemical Pharmacy

    Shanghai Jiaotong University, Shanghai, China

    2001 - 2005

    B.S. in Biotechnology (Fermentation Engineering)

    Shanghai Normal University, Shanghai, China

    Research Interest:

      CRISPR technology

    Stem Cell Research and Therapy

    Gynecological Disease Research

    Autoimmune Disease Research


    RESEARCH INTERESTS AND SKILLS

    My scientific interests are to understand how genetic and molecular programs can yield the complex biological behaviors. As a medical research scientist, synthetic biologist and bioengineer, I am passionate about the applications of diverse biotechnological tools to understand genomics and explore the mechanism of genomic control as well as incidence of diseases, which allow comprehensive understanding, manipulating, and engineering of sophisticated biological systems. I aim to understand cellular or organismal behaviors in both space and time thus benefit the biomedical research, translational studies and cell therapy.
    I am skilled in cell culture (primary/linage) and cellularity detections (CCK8, FACS etc); molecular cloning and detection (plasmid construction, RT-PCR, western blot etc); protein [removed]prokaryotic expression system) and purification (ionexchange and affinity chromatography); immunohistochemistry and immunocytochemistry detection; and animal model construction.


    Research Grant Details:

    National Natural Science Foundation of China (Grant No. 81502233)

    Existing evidence indicates that PPI (protein-protein interaction) contributes to the tumorigenesis of endometrial carcinoma, but the mechanisms involved in it remain largely unknown. In our previous study, we found that ATF3 participating in the development of various different kinds of cancer, expressed higher in the epithelium of normal endometrial tissue than that detected in pathnological tissue, and interacted with JunB which expressing higher in the epithelium of endometrial cancer tissue than that detected in normal endometrial tissue, via yeast-two-hybrid assay. Additionally, over-expression of ATF3 led to the inhibition of cell proliferation, migration and invasion, with the down-regulation of JunB and inflammatory factor. Therefore, we put forward a hypothesis that ATF3 might inhibit the expression of inflammatory genes and the development of endometrial cancer by binding with JunB andmitigating with it. This study was designed to utilize the mRNA expression microarray analysis, CRISPR/Cas9 and orthotopic endometrial carcinoma model in nude mice combined with molecular biological techniques to explore the cell signal transductions of ATF3 and JunB in EC, demonstrate the mechanism of development of EC, and provide new therapeutic targets for it, which contributes greatly to the patients suffering from endometrial cancer.

    PUBLICATIONS

    1.    Wang Fangyuan(#), Qi Stanley Lei(*). Applications of CRISPR Genome Engineering in Cell Biology. Trends in Cell Biology. 2016 Nov;26(11):875-888.

    2.    Wang Fangyuan(#), Zhao Dehua, Qi Lei Stanley(*). Application of genome engineering in medical synthetic biology. Sheng Wu Gong Cheng Xue Bao. 2017 Mar 25;33(3):422-435.

    3.    Wang Fangyuan(#), Gao Jin, Malisani Alyssa, Xi Xiaowei, Han Wei, Wan Xiaoping (*), Mouse Resistin (mRetn): cloning, expression and purification in Escherichia coli and the potential regulative effects on murine bone marrow hematopoiesis. BMC Biotechnol, 2015 Nov 16;15(1):105.

    4.    Wang Fangyuan(#), Wang Li, Yao Xiaofen, Lai Dongmei(*). Human amniotic epithelial cells can differentiate to granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2013 Oct 14;4(5):124-134.

    5.    Liu Yanxia(#), Yu Chen(#), Daley Timothy Patrick(#), Wang Fangyuan, Cao William S., Bhate Salil, Lin Xueqiu, Still II Chris, Liu Honglei, Zhao Dehua, Wang Haifeng, Xie Xinmin S., Ding Sheng, Wong Wing Hung, Wernig Marius, Qi Lei Stanley. CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming. Cell Stem Cell. 2018 Nov 1;23(5):758-771.

    6.    Yan Qin(#), Wang Fangyuan, Miao Yi, Wu Xiaomei, Bai Mingzhu, Xi Xiaowei, Feng Youji(*). Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase. Tumour Biol. 2016 Sep;37(9):12263-12271.

    7.    Lai Dongmei(#)(*), Wang Fangyuan, Yao Xiaofen, Zhang Qiuwan, Wu Xiaoxing, Xiang Charlie(*). Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. J Transl Med. 2015 May 12;13:155.

    8.    Lai Dongmei(#)(*), Wang Fangyuan, Dong Zhangli, Zhang Qiuwan. Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model. PLoS One. 2014 May 30;9(5):e98749.

    9.    Lai Dongmei(#)(*), Wang Fangyuan, Chen Yifei, Wang Li, Wang Yanlin, Cheng Weiwei. Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Dev Biol. 2013 Sep 4;13(1):34.

    10.    Lai Dongmei(#)(*), Wang Fangyuan, Chen Yifei, Wang Chunhui, Liu Sha, Lu Bufeng, Ge Xuerui, Guo Lihe. Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes. Cancer Immunol Immunother. 2012 Jul;61(7):979-89.

    11.    Che Qi(#), Liu Binya, Wang Fangyuan, He Yinyan, Lu Wen, Liao Yun, Gu Wei, Wan Xiaoping(*). Interleukin 6 promotes endometrial cancer growth through an autocrine feedback loop involving ERK-NF-kappaB signaling pathway. Biochem Biophys Res Commun, 2014, 446(1):167-172.

    12.    Lai Dongmei(#)(*), Ma Li, Wang Fangyuan. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Int J Oncol. 2012 Aug;41(2):541-50.

    13.    Lai Dongmei(#)(*), Chen Yifei, Wang Fangyuan, Jiang Lizhen, Wei Chunsheng. LKB1 Controls the Pluripotent State of Human Embryonic Stem Cells. Cellular Reprogramming. April 2012, 14(2): 164-170.

    14.    Chen Zheng(#), Che Qi, He Xiaoying, Wang Fangyuan, Wang Huihui, Zhu Minjiao, Sun Jing(*), Wan Xiaoping(*). Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition. BMC Cancer, 2015 Oct 27;15:811.

    15.    Chen Zheng(#), Che Qi, Jiang Feizhou, Wang Huihui, Wang Fangyuan, Liao Yun, Wan Xiaoping(*). Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer. Biochem Biophys Res Commun, 2015 Aug 7;463(4):876-80.

    16.    Liao Yun(#), He Xiaoying, Qiu Haifeng, Che Qi, Wang Fangyuan, Lu Wen, Chen Zheng, Qiu Meiting, Wang Jingyun, Wang Huihui, Wan Xiaoping(*). Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer. BMC Cancer. 2014, 14:487。

    17.    Huang Haili(#), Wang Yajing, Zhang Qingyu, Liu Bin, Wang Fangyuan, Li Jingjing, Zhu Runzhi(*). Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice. World J Gastroenterol 2012 Dec 7;18(45):6605-6613.

    18.    Wang Huihui(#), Bao Wei, Jiang Feizhou, Che Qi, Chen Zheng, Wang Fangyuan, Tong Huan, Dai Chenyun, He Xiaoying, Liao Yun, Liu Binya, Sun Jing, Wan Xiaoping(*). Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGgamma. Cancer Lett. 2015 May 1;360(2):269-79.

    19.    Xia Peng(#), Gao Jin, Guan Wen, Li Jingjing, Yu Xiaolan, Wang Fangyuan, He Honglin, Deng Qing, Zhou Liang, Yuan Yunsheng, Han Wei(*), Yu Yan(*). Production of bioactive recombinant rat soluble receptor for advanced glycation end products (rrsRAGE) in Pichia pastoris. Protein Expr Purif, 2017 Oct;138:81-87.

    20.    Zhu Minjiao(#), Che Qi, Liao Yun, Wang Huihui, Wang Jingyun, Chen Zheng, Wang Fangyuan, Dai Chenyun, Wan Xiaoping(*). Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis. Oncol Rep. 2015 Jul;34(1):129-38.

    21.    Che Qi(#), Liu Binya, Liao Yun, Zhang Huijuan, Yang Tingting, He Yinyan, Xia Yuhong, Lu Wen, He Xiaoying, Chen Zheng, Wang Fangyuan, Wan Xiaoping(*). Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironment. Int J Cancer. 2014 Jul 15;135(2):282-94.

    22.    Liu Yuan(#), Murray-Stewart T, Casero RA Jr, Kagiampakis I, Jin L, Zhang J, Wang H, Che Qi, Tong Huan, Ke Jieqi, Jiang Feizhou, Wang Fangyuan, Wan Xiaoping(*). Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth. Int J Oncol. 2017 Jun;50(6):2011-2023.

    23.    Ke Jieqi(#), Yang Yixia(#), Che Qi, Jiang Feizhou, Wang Huihui, Chen Zheng, Zhu Minjiao, Tong Huan, Zhang Huilin, Yan Xiaofang, Wang X, Wang Fangyuan, Liu Yuan, Dai Chenyun, Wan Xiaoping(*). Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer. Tumour Biol. 2016 Sep;37(9):12203-12211.

    24.    Jiang Feizhou(#), He Yinyan, Wang Huihui, Zhang Huilin, Zhang Jian, Yan Xiaofang, Wang Xiaojun, Che Qi, Ke Jieqi, Chen Zheng, Tong Huan, Zhang Yongli, Wang Fangyuan, Li Yiran, Wan Xiaoping(*). Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Oncotarget, 2015 Dec 29;6(42):44660-74.

    (#) First Author, (*) Correspondence Author.


    More Info.
    Guojun Wu
    Associate Professor
    Department of Oncology
    Wayne State University School of Medicine
    USA
    wugu@karmanos.org
    SSCRT

    Research Interest:

    Two Major Projects are Currently Underway in the Laboratory.
    A Cell Reprogramming Technique Has Been Used to Convert Heterogeneous Malignant Breast Cancer Cells into Induced Pluripotent Stem Cells Using Sox2/Oct4/Nanog Proteins. Dr. Wu’s Laboratory is Clarifying these Induced Pluripotent Stem Cells for their Differentiation Potential and Oncogenic Properties, and Try to Develop a Novel Cell Converting Therapy for Malignant Breast Cancer Treatment.
    Metastasis, the Spread of Cancer Cells from the Primary Tumor To Distant Organs, Is The Most Dreadful Development Of Breast Cancer, As Well As Other Neoplastic Diseases. Although Metastasis Contributes To Over 90% Of Human Cancer Mortality, The Molecular Mechanism Of This Process Remains Largely Unknown. Dr. Wu’s Laboratory Is In The Process Of Identifying Molecular Signatures Involved In Breast Cancer Metastasis Using Integrative Genetic, Epigenetic And Proteomic Approach, As Well As Animal Models And Clinical Specimens. 

    More Info.
    Xiangxin Lou
    College of Chemistry, Chemical Engineering and Biotechnology
    Donghua University
    China
    xiangxin@dhu.edu.cn
    SSCRT

    Research Interest: Cell Reprogramming and Induced Pluripotent Stem Cells, Stem Cells and Neural Tissue Engineering, Mammalian Inner Ear Development and Hair Cell Regeneration.

    More Info.
    Filomain Nguemo
    Institute of Neurophysiology
    Medical School University of Cologne
    Germany
    filo.nguemo@uni-koeln.de
    SSCRT

    Research Interest: Therapeutic Application of ES and Ips Cells.

    More Info.
    Guillermo Estivill-Torrus
    Civil Hospital Research Laboratory
    Spain
    guillermo.estivill@ibima.eu
    SSCRT

    Research Interest: Neuropsychopharmacology of Lipid Transmitters (CTS643, Andalusian Ministry of Economy, Innovation, Science and Employment): The Group is Formed in the University Regional Hospital of Malaga, in Collaboration with the University of Malaga, and Integrated Into the Biomedical Research Institute of Malaga (IBIMA). Our Interest Focuses on the Role that Regulatory Lipid Molecules, Mainly Lysophosphatidic Acid, Exerted on the Central Nervous System and Related Mainly to the Neural Genesis (Neurogenesis / Gliogenesis) and its Effect on Behavioral Level. It Also Examines the Role of Lysophosphatidic Acid in the Dynamic Processes that Regulate Neuroinflammation and Demyelination in Multiple Sclerosis, Studying Animal Models and Samples from Patients with Multiple Sclerosis, As Well As Mesenchymal Cell Therapy for the Disease.

    More Info.
    Jianbo Wu
    Postdoctoral Fellow
    University of Texas Health Science Center at Houston
    USA
    Jianbo.Wu@uth.tmc.edu
    SSCRT

    Research Interest: ES/Ips Cells; Skeletal Muscle Regeneration; Gene and Cell Therapy; Genome Editing; Gene Targeting. 

    More Info.
    Yuval Rinkevich
    Department of Pathology
    Stanford University
    USA
    yuvalrinkevich@gmail.com
    SSCRT

    Research Interest: Regenerative Biology (Marine Invertebrates and Mammals), Stem Cell Biology, Developmental Biology.

    More Info.
    Jesus Vaquero
    Professor
    Department of Neurosurgery
    Autonomous University
    Spain
    jvaqueroc@telefonica.net
    SSCRT

    Research Interest: Neurological Disability.

    More Info.
    Devyn M Smith
    Pharma Therapeutics Division
    Worldwide Research and Development
    USA
    Devyn.M.Smith@pfizer.com
    SSCRT

    Research Interest: In his Consulting Experience, Devyn Led a Wide Range of Projects, Across Multiple Therapeutic Areas and a Host of Technology Platforms, Including Basic R&D Tools, Regenerative Medicine, Gene Therapy and Macromolecules/Biologic Products.

    More Info.
    Xiefan Fang
    Department of Pediatrics
    University of Florida
    USA
    xiefanfang@ufl.edu
    SSCRT

    Research Interest: Cardiology, Toxicology, Epigenetics, Stem Cell Differentiation, and Bioinformatics.

    More Info.
    Valarmathi Mani Thiruvanamalai
    Department of Comparative Biosciences
    University of Illinois
    USA
    valarmathi64@hotmail.com
    SSCRT

    Research Interest: Cardiac Therapy, Cardiovascular Disease, Autologous, Tissue-Engineering, Multipotent Stem Cells, Cardiovascular Structures, Regenerative Medicine.

    More Info.
    Ambrish Kumar
    Department of Pathology, Microbiology and Immunology
    University of South Carolina
    USA
    Ambrish.Kumar@uscmed.sc.edu
    SSCRT

    Research Interest: Cancer Stem Cell, Anticancer Agent, Metastasis, Cell Survival, Cell Migration, Apoptosis, Molecular and Cell Signaling, Transcription Factors, Xenograft Model, Stem Cell Based Therapy.

    More Info.
    Manoj Gupta
    Research Fellow
    Joslin Diabetes Center
    USA
    manoj.gupta@joslin.harvard.edu
    SSCRT

    Research Interest: Leptin Receptors (Lepr) are Expressed by Various Types of Stem Cells Including Mesenchymal Stem Cells, Hematopoietic Stem Cells, Embryonic Stem Cells and Induced Pluripotent Stem Cells. Leptin/Lepr Signaling is also a Central Regulator of Metabolism.

    More Info.
    Han Wang
    Department of Cellular and Structural Biology
    University of Texas
    USA
    cherrywangh@hotmail.com
    SSCRT

    Research Interest: Embryonic Stem Cells, Pluripotency, Induced Pluripotent Cells, Differentiation, Endoderm, Beta Cell, Diabetes, Obesity, Adipose Tissue, Brown Fat, Endothelium, Oxidative Stress, Nitric Oxide, Peroxynitrite, Superoxide, Nanosensors.

    More Info.
    View more
    mendeley

    Tracking of Covid-19 in Libya

    Published On: May 27, 2020 | Pages: 016 - 017

    Author(s): Aisha Nasef* and Adel El Taguri
    Abstract View Full Article View
    mendeley

    Effect of culture environement on mesenchymal stem cell immunomodulatory ability

    DOI Logo 10.17352/sscrt.000015

    Published On: April 11, 2020 | Pages: 009 - 015

    Author(s): Aisha Nasef*, Alain Chapel and Loic Fouillard
    Abstract View Full Article View
    mendeley

    Bovine whey improved the myocardial and lung damage of mother rats fed on a high fat diet

    DOI Logo 10.17352/sscrt.000014

    Published On: February 28, 2020 | Pages: 001 - 008

    Author(s): Hassan IH El-Sayyad*, Hebat A el-Ghawet, Khaled SM El-Bayomi and Eman Emara
    Abstract View Full Article View
    mendeley

    The potential effects of pomegranate peel extract and bee venom in improving the diabetes induced damaging of spiral artery

    DOI Logo 10.17352/sscrt.000013

    Published On: December 27, 2019 | Pages: 007 - 011

    Author(s): El-Sayyad HIH*, El-Ghawet HA and El-Sayed AMA
    Abstract View Full Article View
    mendeley

    Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group

    DOI Logo 10.17352/sscrt.000012

    Published On: August 03, 2019 | Pages: 000 - 006

    Author(s): Mehmet Ali Uçar*, Simten Dağdaş, Funda Ceran, Mesude Falay and Gülsüm Özet
    Abstract View Full Article View
    mendeley

    Cell-Penetrating Peptides as a Tool to Deliver Biologically Active Recombinant Proteins to Generate Transgene-Free Induced Pluripotent Stem Cells

    DOI Logo 10.17352/sscrt.000011

    Published On: April 01, 2017 | Pages: 006 - 015

    Author(s): Chandrima Dey, Gloria Narayan, H Krishna Kumar, Manash P Borgohain, Nibedita Lenka and Rajkumar P Thummer*
    Abstract View Full Article View
    mendeley

    Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence

    DOI Logo 10.17352/sscrt.000010

    Published On: December 31, 2016 | Pages: 001 - 005

    Author(s): Elgin OZKAN*, Mine ARAZ, Cigdem SOYDAL and Gulseren ARAS
    Abstract View Full Article View
    mendeley

    Adipogenic and Osteogenic Markers Characterization of Human Amniotic Fluid Stem Cells

    DOI Logo 10.17352/sscrt.000009

    Published On: December 29, 2016 | Pages: 025 - 032

    Author(s): Hassan IH El-Sayyad*, Mohamed A Sobh, Soad A Khalifa, Omnia KRA El-Sayyad
    Abstract View Full Article View
    mendeley

    Adipose Derived Mesenchymal Stem Cell Differentiation into Adipogenic and Osteogenic Stem Cells

    DOI Logo 10.17352/sscrt.000008

    Published On: December 29, 2016 | Pages: 017 - 024

    Author(s): Hassan IH El Sayyad1*, Mohamed A Sobh2, Soad A Khalifa1 and Omnia KR El-Sayyad
    Abstract View Full Article View
    mendeley

    A New Catheter Technology to Deliver Vascular Stem-Cells

    DOI Logo 10.17352/sscrt.000007

    Published On: December 13, 2016 | Pages: 007 - 016

    Author(s): Brian D Plourde, John R Stark and John P Abraham*
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on SSCRT